Literature DB >> 22088336

Incidental detection of renal cell carcinoma is an independent prognostic marker: results of a long-term, whole population study.

Helga Bjork Palsdottir1, Sverrir Hardarson, Vigdis Petursdottir, Armann Jonsson, Eirikur Jonsson, Martin Ingi Sigurdsson, Gudmundur Vikar Einarsson, Tomas Gudbjartsson.   

Abstract

PURPOSE: The true effect of incidental detection on the survival of patients with renal cell carcinoma has been debated. We used centralized databases in Iceland to study prognostic factors of survival, focusing on the effect of incidental detection.
MATERIALS AND METHODS: This retrospective study included all living patients diagnosed with renal cell carcinoma in Iceland from 1971 to 2005. Hospital charts and histology were reviewed. Incidentally diagnosed renal cell carcinomas were compared to symptomatic tumors and prognostic factors were evaluated using Cox multivariate analysis.
RESULTS: Of the 910 patients 254 (27.9%) were diagnosed incidentally, most often by abdominal ultrasound (29.5%) or computerized tomography (28.3%). The incidental detection rate increased from 11.1% in 1971 through 1975 to 39.2% in 2001 through 2005 (p <0.001). During the same period the incidence increased significantly in males but in females only during the last 5 study years. Mortality remained unchanged for each gender. Incidentally detected tumors were an average of 2.6 cm smaller and diagnosed at lower stage and lower grade than symptomatic tumors. Age and histology were similar in each group. TNM stage was by far the strongest independent prognostic factor of survival but age, calendar year of diagnosis and ESR were also significant. After correcting for confounders patients with symptomatic renal cell carcinoma had worse survival than those diagnosed incidentally.
CONCLUSIONS: With increased incidence and unchanged mortality the survival of patients with renal cell carcinoma has improved. This is mainly related to a steep increase in incidental detection. Incidental detection affects survival favorably and to a greater extent than can be explained by lower stage compared to the survival of patients diagnosed with symptoms.
Copyright © 2012 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22088336     DOI: 10.1016/j.juro.2011.09.025

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  19 in total

1.  End-Stage Kidney Disease following Surgical Management of Kidney Cancer.

Authors:  Robert J Ellis; Daniel P Edey; Sharon J Del Vecchio; Megan McStea; Scott B Campbell; Carmel M Hawley; David W Johnson; Christudas Morais; Susan J Jordan; Ross S Francis; Simon T Wood; Glenda C Gobe
Journal:  Clin J Am Soc Nephrol       Date:  2018-09-28       Impact factor: 8.237

2.  The impact of routine whole spine MRI screening in the evaluation of spinal degenerative diseases.

Authors:  Rishi Mugesh Kanna; Younis Kamal; Anupama Mahesh; Prakash Venugopal; Ajoy Prasad Shetty; S Rajasekaran
Journal:  Eur Spine J       Date:  2017-01-21       Impact factor: 3.134

3.  Laparoscopic partial nephrectomy with diode laser: a promising technique.

Authors:  Nikola Knezevic; Tomislav Kulis; Marjan Maric; Marija Topalovic Grkovic; Ivan Krhen; Zeljko Kastelan
Journal:  Photomed Laser Surg       Date:  2014-01-24       Impact factor: 2.796

Review 4.  Pathological Bases and Clinical Impact of Intratumor Heterogeneity in Clear Cell Renal Cell Carcinoma.

Authors:  José I López; Javier C Angulo
Journal:  Curr Urol Rep       Date:  2018-01-27       Impact factor: 3.092

5.  Clinicohistological characteristics of renal cell carcinoma in children: A multicentre study.

Authors:  Jeong Ho Kim; Seong Il Seo; Cheryn Song; Jinsoo Chung; Cheol Kwak; Sung-Hoo Hong
Journal:  Can Urol Assoc J       Date:  2015-10-13       Impact factor: 1.862

6.  Is the routine use of magnetic resonance imaging indicated in patients with scoliosis?

Authors:  Varun Dewan; Adrian Gardner; Stephen Forster; Jake Matthews; Matthew Newton Ede; Jwalant Mehta; Jonathan Spilsbury; David Marks
Journal:  J Spine Surg       Date:  2018-09

Review 7.  Serum and urine biomarkers for human renal cell carcinoma.

Authors:  A L Pastore; G Palleschi; L Silvestri; D Moschese; S Ricci; V Petrozza; A Carbone; A Di Carlo
Journal:  Dis Markers       Date:  2015-04-02       Impact factor: 3.434

8.  Associations between presenting symptoms, clinicopathological parameters, and prognosis in a contemporary series of patients with renal cell carcinoma.

Authors:  Sebastian L Hofbauer; Michela de Martino; Christoph Seemann; Nura Zamani; Ilaria Lucca; Andrea Haitel; Shahrokh F Shariat; Tobias Klatte
Journal:  Korean J Urol       Date:  2014-08-08

9.  What's more general than a whole population?

Authors:  Neal Alexander
Journal:  Emerg Themes Epidemiol       Date:  2015-08-25

10.  A proposal for a targeted screening program for renal cancer.

Authors:  Michael W Shea
Journal:  Front Oncol       Date:  2013-08-20       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.